Redsense Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-7.17	0.34	-4.51	-8.76	-7.97	Upgrade
Depreciation & Amortization	0.63	0.07	0.06	0.05	0.03	Upgrade
Other Amortization	-	-	-	-	0.15	Upgrade
Other Operating Activities	1.84	-1.08	-1.58	-0.08	-2.29	Upgrade
Change in Accounts Receivable	-0.57	-1.73	0.98	-1.29	-1.08	Upgrade
Change in Inventory	-2.72	-4.63	0.18	-0.1	0.91	Upgrade
Change in Other Net Operating Assets	2.76	-1.2	-0.17	0.4	-1.97	Upgrade
Operating Cash Flow	-5.22	-8.23	-5.05	-9.78	-12.22	Upgrade
Capital Expenditures	-0.01	-0.02	-0.05	-0.05	-0.36	Upgrade
Sale (Purchase) of Intangibles	-2.78	-0.59	-0.55	-2.41	-8.86	Upgrade
Investment in Securities	-	-	8.95	13.33	-0.5	Upgrade
Other Investing Activities	-	-	-	-	-0	Upgrade
Investing Cash Flow	-2.79	-0.61	8.35	10.87	-9.71	Upgrade
Long-Term Debt Issued	-	-	-	-	2.57	Upgrade
Long-Term Debt Repaid	-	-	-	-2.57	-	Upgrade
Net Debt Issued (Repaid)	-	-	-	-2.57	2.57	Upgrade
Issuance of Common Stock	0.02	17.23	-	-	-	Upgrade
Common Dividends Paid	-	-	-	-	-4.46	Upgrade
Other Financing Activities	-	-	-	0.18	-	Upgrade
Financing Cash Flow	0.02	17.23	-	-2.4	-1.89	Upgrade
Foreign Exchange Rate Adjustments	-	-	-	-	-0.21	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-	Upgrade
Net Cash Flow	-8	8.39	3.29	-1.31	-24.02	Upgrade
Free Cash Flow	-5.24	-8.25	-5.1	-9.83	-12.58	Upgrade
Free Cash Flow Margin	-19.54%	-28.66%	-20.00%	-58.68%	-76.98%	Upgrade
Free Cash Flow Per Share	-0.32	-0.48	-0.36	-0.70	-0.90	Upgrade
Levered Free Cash Flow	-7.29	-7.99	-2.73	-9.9	-19.17	Upgrade
Unlevered Free Cash Flow	-7.29	-7.97	-2.71	-9.84	-19.13	Upgrade
Change in Working Capital	-0.52	-7.56	0.98	-1	-2.13	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.